Sort
82,697 grants matching “vaccine development”
Product Development and Manufacture
$1,229,292Robert T McNally · Geovax, Inc. · U19 · FY2008 · AI
Penn prevention clinical trials unit
$1,228,585David S Metzger · University Of Pennsylvania · U01 · FY2007 · AI
Core B - Genomics Core
$1,228,348Steven M Wolinsky · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Malaria Vaccines: AMA1-rEPA/ALHYDROGEL + CPG 7909
$1,228,315Laura Martin · Niaid Extramural Activities · Z01 · FY2007 · AI
Env evolution in humans and RMs
$1,228,300George M Shaw · University Of Pennsylvania · P01 · FY2017 · AI
Control of Autoimmunity by Regulatory T Cells
$1,228,133Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Task 16 (E11): EVALUATION OF THE IMMUNOGENICITY OF FILOVIRUS VACCINES
$1,227,931Lovelace Biomedical & Environmental Research Institute · N01 · FY2009 · AI
A novel vaccine against multidrug-resistant gonorrhea
$1,227,829Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
$1,227,827Sallie R. Permar · Duke University · P01 · FY2020 · AI
Molecular Biology Of Retroviruses Associated With AIDS
$1,227,557Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
University of California, San Diego Clinical Trial Unit
$1,227,553Stephen A Spector · University Of California, San Diego · UM1 · FY2013 · AI
Cornell Clinical Trials Unit
$1,227,503Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2011 · AI
Mechanisms of immune-mediated protection and pathogenesis during viral infections
$1,227,442Julie Fox · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms Of Humoral Evasion
$1,227,402Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
$1,227,385John H Sampson · Annias Immunotherapeutics, Inc. · R42 · FY2015 · CA
The connection of innate and adaptive anti-cancer immunity
$1,227,316John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Cancer Prevention by Vaccination against Induced Antigens
$1,227,167Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2019 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,227,024Robert Simpson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Therapeutics for Pox, Filo and Other Viral Pathogens
$1,226,999Auburn University At Auburn · U19 · FY2005 · AI
New Vaccine Surveillance Network
$1,226,950John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · IP
Enhanced Surveillance for Newly preventable Diseases (ARI and AGE Surveillance) Rochester, NY
$1,226,950Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2018 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,226,950Janet A Englund · Seattle Children'S Hospital · U01 · FY2018 · IP
TASK ORDER B-15: Model Development and Medical Countermeasure Evaluation
$1,226,781Niurka De Leon · Boston University Medical Campus · N01 · FY2023 · AI
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$1,226,752Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Herpesviruses as Vaccine Vectors for AIDS
$1,226,620David M Knipe · Harvard Medical School · P01 · FY2008 · AI